Insulin degludec/liraglutide, sold under the brand name Xultophy, is a fixed-dose combination medication for the treatment of adults with type 2 diabetes to improve glycemic control in combination ...

Inhaled insulin was noninferior to usual care in glycemic control outcomes after 17 weeks among patients with type 1 diabetes.

A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...

A regimen of inhaled Technosphere insulin and insulin degludec is just as good as usual care for glycaemic control, new evidence has indicated. During the study, the team of researchers from the ...

What does it do? Victoza is a medicine primarily used to treat type 2 diabetes, by increasing the amount of insulin released. How is it taken? Victoza is an injection that you take once a day. Where ...

While this option may be less expensive and seems convenient, it’s best to consult a doctor about dosage if you use it, says Joshua J. Neumiller, CDCES, PharmD, the president elect of ...

“They also enhance insulin sensitivity and lower insulin ... In a study using pancreatic cancer cell lines, GLP-1 liraglutide suppressed cancer cell growth and led to cell death.

Additional warnings include pancreatitis, liraglutide pen sharing, hypoglycemia when used in conjunction with certain other drugs known to cause hypoglycemia like insulin and sulfonylurea ...

b.i.d.: Twice daily; LEAD: Liraglutide Effect and Action Diabetes ... for the 'incretin effect', a phenomenon in which where more insulin is secreted in response to glucose ingested during ...